🧬 Targeting Aldosterone: A New Shot at Hypertension 🎯💥
Jul 05, 2025•4 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
🚨 New breakthrough in hypertension care!
💊 The Launch-HTN trial shows lorundrostat — a selective aldosterone synthase inhibitor — significantly lowers systolic BP in patients with uncontrolled or treatment-resistant hypertension.
📉 −16.9 mmHg vs −7.9 mmHg with placebo (P < .001)
🧪 Safe, well-tolerated, and effective across subgroups.
A potential game-changer in aldosterone-targeted therapy! 🔄💥 #Hypertension #Cardiology #ClinicalTrials #PrecisionMedicine
For the best experience, listen in Metacast app for iOS or Android